Insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in benign prostatic hyperplasia and prostate cancer

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 2, 2001, Pages 694-699

  Khosravi, Javad ^a,c,d   Diamandi, Anastasia ^a   Mistry, Jehangir ^b   Scorilas, Andreas ^c  

^a Diagnostic Systems Laboratories   (Canada)

^b Diagnostic Systems Laboratories Inc   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; RECEIVER OPERATING CHARACTERISTIC;

EID: 0035092756     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.86.2.7211     Document Type: Article

References (50)

1. Insulin-like growth factor binding proteins: Structural and molecular relationships
2. Physiologic and clinical relevance of the insulin-like growth factor binding proteins
3. Insulin-like growth factors and their binding proteins: Biological actions
4. Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulation and functions
5. Insulin-like growth factor binding proteins: A proposed supperfamily
6. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics
7. Insulin-like growth factor binding proteins: New proteins, new functions
8. Growth inhibition by insulin-like growth factor (IGF) binding protein-3: What's IGF got to do with it
9. The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene
10. The 16-kDa proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 inhibits the mitogenic action of fibroblasts growth factor on mouse fibroblasts with a targeted disruption of the typed IGF receptor gene
11. Insulin-like growth factor-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β on programmed cell death through a p53- and IGF-independent mechanisms
12. IGF-independent regulation of breast cancer growth by IGF binding proteins
13. Insulin-like growth factor binding protein (IGFBP) proteases: Functional regulations of cell growth
14. IGF binding protein-3 protease regulation: How sweet it is
15. Growth factor involvement in progression of prostate cancer
16. Insulin-like growth factor and new opportunities for cancer prevention
17. Circulating IGF-I: New perspectives for a new century
18. Serum insulin-like growth factor-I levels and prostate cancer risk: Interpreting the evidence
19. The insulin-like growth factor I receptor: A key to tumor growth?
20. Expression of insulin-like growth factor (IGF)-II in human prostate, breast, bladder, and paraganglioma tumors
21. Insulin-like growth factors in central nervous system tumors
22. Blockade of the insulin-like growth factor-I receptor inhibits growth of human colorectal cancer cells: Evidence of a functional IGF-II-mediated autocrine loop
23. Growth hormone and prostate cancer: Guilty by association?
24. Effects of growth hormone (GH) and insulin-like growth factor I on prostate diseases: An ultrasonographic and endocrine study in acromegaly. GH deficiency, and healthy subjects
25. Increased epithelial cell proliferation in the colon of patients with acromegaly
26. Mortality and cancer incidence in acromegaly: A retrospective cohort study
27. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study
28. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer
29. Insulin-like growth factor-I and prostate cancer risk: A population-based, case control study
30. Plasma levels of insulin-like growth factor-I and lung cancer risk: A case-control analysis
31. IGF-I and IGF-II in relation to colorectal cancer
32. Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma
33. The prostate: An increasing medical problem
34. Prostate specific antigen: Its usefulness in clinical medicine
35. Prostate cancer detection in men with serum PSA concentrations of 2.6-4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements
36. Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen
37. Use of percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostate disease: A prospective multicenter clinical trial
38. A non-competitive ELISA for human serum insulin-like growth factor-I
39. Insulin-like growth factors (IGF-I, free IGF-I, and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation
40. Immunoassay of insulin-like growth factor binding protein-3: New means to quantifying IGFBP-3 proteolysis
41. Immunoassay of insulin-like growth factor binding protein-1
42. Synthesis of IGFBP-3 fragments in a baculovirus system and characterization of monoclonal anti-IGFBP-3 antibodies
43. The high molecular weight insulin-like growth factor binding protein complex: Epitope mapping, immunoassay, and preliminary clinical evaluation
44. Analytical performance of the Tandem-R free PSA immunoassay measuring free prostate-specific antigen
45. Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) proteolysis in patients with colorectal cancer: Possible association with the metastatic potential of the tumor
46. 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: Assay of the complex improves clinical sensitivity for cancer
47. 1-antichymotrypsin in prostate carcinoma
48. Prostate specific antigen in benign prostatic hyperplasia: Purification and characterization
49. Insulin-like growth factor binding protein-3 and breast cancer survival
50. Insulin-like growth factor binding protein-3 (IGFBP-3) is associated with breast cancer risk